PATTERNS OF CHRONIC KIDNEY DISEASE – MINERAL BONE DISEASE AND ITS RELATIONSHIP WITH SOCIO-DEMOGRAPHIC FACTORS AMONG THE PATIENTS OF CHRONIC KIDNEY DISEASE UNDERGOING HEMODIALYSIS

by Batool Butt, Taymmia Ejaz, Sohail Sabir, Ghayas Khan
Published 2021-01-01

A Role of Intestinal Alkaline Phosphatase 3 (Akp3) in Inorganic Phosphate Homeostasis

by Shohei Sasaki, Hiroko Segawa, Ai Hanazaki, Ruri Kirino, Toru Fujii, Kayo Ikuta, Miwa Noguchi, Sumire Sasaki, Megumi Koike, Kazuya Tanifuji, Yuji Shiozaki, Ichiro Kaneko, Sawako Tatsumi, Takaaki Shimohata, Yoshichika Kawai, Sonoko Narisawa, José Luis Millán, Ken-ichi Miyamoto
Published 2018-09-01

Energy-Dense Diets and Mineral Metabolism in the Context of Chronic Kidney Disease–Metabolic Bone Disease (CKD-MBD)

by Mariano Rodriguez, Escolastico Aguilera-Tejero
Published 2018-12-01

Association between serum fibroblast growth factor‐23 concentration and development of hyperphosphatemia in normophosphatemic dogs with chronic kidney disease

by Hirosumi Miyakawa, Huai‐Hsun Hsu, Mizuki Ogawa, Ryota Akabane, Yuichi Miyagawa, Naoyuki Takemura
Published 2021-09-01

Impact of physical activity and exercise on bone health in patients with chronic kidney disease: a systematic review of observational and experimental studies

by Daniela F. Cardoso, Elisa A. Marques, Diogo V. Leal, Aníbal Ferreira, Luke A. Baker, Alice C. Smith, João L. Viana
Published 2020-08-01

The stability and variability of serum and plasma fibroblast growth factor-23 levels in a haemodialysis cohort

by Matthew J. Damasiewicz, Zhong X. Lu, Peter G. Kerr, Kevan R. Polkinghorne
Published 2018-11-01

Aortic stenosis is a risk factor for all-cause mortality in patients on dialysis: a multicenter prospective cohort analysis

by Daijo Inaguma, Yuji Sasakawa, Noriko Suzuki, Eri Ito, Kazuo Takahashi, Hiroki Hayashi, Shigehisa Koide, Midori Hasegawa, Yukio Yuzawa, Tokai Aortic Stenosis in Dialysis Patients Cohort Study Group
Published 2018-04-01

Modifying Phosphate Toxicity in Chronic Kidney Disease

by Marc Vervloet
Published 2019-09-01

Treatment of secondary hyperparathyroidism: the clinical utility of etelcalcetide

by Cozzolino M, Galassi A, Conte F, Mangano M, Di Lullo L, Bellasi A
Published 2017-06-01

Association between Allelic Variations of -174G/C Polymorphism of Interleukin-6 Gene and Chronic Kidney Disease-Mineral and Bone Disorder in Iraqi Patients

by Mohanad Radeef
Published 2020-12-01

Emerging Effects of Sevelamer in Chronic Kidney Disease

by Ryota Ikee, Masataka Tsunoda, Naomi Sasaki, Naritsugu Sato, Nobuo Hashimoto
Published 2013-03-01

The Off-Target Effects, Electrolyte and Mineral Disorders of SGLT2i

by Giuseppe Cianciolo, Antonio De De Pascalis, Lorenzo Gasperoni, Francesco Tondolo, Fulvia Zappulo, Irene Capelli, Maria Cappuccilli, Gaetano La La Manna
Published 2020-06-01

A Prospective Cohort Study Showing No Association Between Serum Sclerostin Level and Mortality in Maintenance Hemodialysis Patients

by Madoka Sato, Norio Hanafusa, Hiroshi Kawaguchi, Ken Tsuchiya, Kosaku Nitta
Published 2018-06-01

FGF23: de la nefrología de salón a la cabecera del paciente

by María Luisa González-Casaus, Emilio Gonzalez-Parra, Pilar Fernandez-Calle, Antonio Buño-Soto
Published 2021-05-01

CKD-MBD: un caso “resistente”

by Maria Polidoro
Published 2014-11-01

Changes in 3-month mineral and bone disorder patterns were associated with all-cause mortality in prevalent hemodialysis patients with secondary hyperparathyroidism

by Chihiro Kato, Naohiko Fujii, Chisato Miyakoshi, Shinji Asada, Yoshihiro Onishi, Shingo Fukuma, Takanobu Nomura, Michihito Wada, Masafumi Fukagawa, Shunichi Fukuhara, Tadao Akizawa
Published 2020-10-01

CKD 5D Asia—what is common and what is different from the West?

by Kunitoshi Iseki
Published 2018-09-01

Fibroblast growth factor 23 and cardiovascular disease in patients with chronic kidney disease

by Kosaku Nitta
Published 2018-08-01

Systemic Activation of Activin A Signaling Causes Chronic Kidney Disease-Mineral Bone Disorder

by Toshifumi Sugatani
Published 2018-08-01

A Changing Perspective for Treatment of Chronic Kidney Disease

by Giacomo Garibotto
Published 2021-08-01